• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

Rayus Radiology Acquires Leading Radiology Provider in Central Florida and Research Institute as It Continues to Accelerate Its National Growth Strategy

Share:

July 15, 2021

RAYUS Radiology, formerly Center for Diagnostic Imaging, a leading national provider of advanced diagnostic and interventional radiology backed by Wellspring Capital Management, announces the acquisition of three imaging centers, known as Sand Lake Imaging in Orlando, Florida, and a majority interest in The Radiology Research Institute, a joint venture with Dr. Stephen Bravo, an expert in neuroradiology, musculoskeletal radiology, and interventional radiology who has built a strong foundation of partnerships with clinical trial sponsors.

The Radiology Research Institute will continue to provide imaging and radiology expertise on a wide variety of clinical trials for its research partners, with a focus on Alzheimer’s Disease, Multiple Sclerosis, Parkinson’s Disease, Non-Alcoholic Steatohepatitis, and Irritable Bowel Disease.

The RAYUS Radiology network is currently involved in more than 150 clinical trial protocols, offering advanced imaging options across every modality through its national network of diagnostic imaging centers and leading subspecialized radiologists. Through the institute, RAYUS Radiology will be able to offer its patients even greater access to innovative treatments and technologies.

“With this partnership, we are effectively combining two research facilities into one of the most comprehensive and progressive research organizations of its kind,” said RAYUS Radiology Chief Executive Officer Kim Tzoumakas. “We look forward to working closely with Dr. Bravo, and outside research partners to advance cutting-edge treatments and improve quality of life for our patients.”

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

“I am excited to partner with RAYUS Radiology to provide cutting edge research solutions and management services,” Dr. Bravo said. “Together, we will be able to pool our significant resources and collective knowledge to support these important trials and advance new scientific discoveries.”

With its most recent acquisition, RAYUS Radiology adds three Central Florida high-quality imaging centers to its existing footprint in the region. The three locations offer state-of-the-art radiology, including MRI, CT, X-Ray, and mammography services for patients seven days a week. With the acquisition, RAYUS Radiology also adds eight additional highly trained subspecialist radiologists to its network.

“We are thrilled to join RAYUS Radiology, as we share the same passion for providing the highest quality, accessible radiology services to our community,” Dr. Robert Posniak said. “I look forward to continuing to be the partner of choice for patients, payors, and referring physicians as part of RAYUS Radiology.”

For RAYUS Radiology, the acquisition of Sand Lake Imaging and the launch of the Radiology Research Institute is the latest in a series of major announcements and aggressive growth strategies that follow Wellspring Capital Management’s acquisition in March 2019. Last week, the company announced its comprehensive rebrand and relaunch as RAYUS Radiology.

Source: Biospace

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • Flow Raises $1.5m, Healthy.io Makes UTI Test Kits Available in UK Boots Pharmacies, and More News BriefsFlow Raises $1.5m, Healthy.io Makes UTI Test Kits Available in UK Boots Pharmacies, and More News Briefs
  • Bayer And Arvinas To Collaborate On Human PROTAC® Therapies And Launch A Separate Joint Venture To Develop Agricultural PROTAC® ApplicationsBayer And Arvinas To Collaborate On Human PROTAC® Therapies And Launch A Separate Joint Venture To Develop Agricultural PROTAC® Applications
  • AMIA Backs NIH Data Sharing Policy, Calls for Phased ImplementationAMIA Backs NIH Data Sharing Policy, Calls for Phased Implementation
  • CBC Group-Backed Hasten Biopharma Successfully Completes Acquisition of Five Cardiovascular and Metabolism Drugs from TakedaCBC Group-Backed Hasten Biopharma Successfully Completes Acquisition of Five Cardiovascular and Metabolism Drugs from Takeda
  • Millennials Demand More Total Wellbeing Support In New ReportMillennials Demand More Total Wellbeing Support In New Report
  • 3M’s Guide For Designing Wearable Medical Devices3M’s Guide For Designing Wearable Medical Devices
  • BlueWhale Bio Founded with $18M Financing led by Danaher Ventures to Accelerate Cell Therapy Manufacturing.BlueWhale Bio Founded with $18M Financing led by Danaher Ventures to Accelerate Cell Therapy Manufacturing.
  • As Telehealth Surges, Are Seniors Being Left Behind?As Telehealth Surges, Are Seniors Being Left Behind?

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications